Sep 06, 2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Pancreatic Cancer Diagnostic Market.

It was estimated prior to this unanticipated outbreak that the Pancreatic Cancer Diagnostic Market was expected to grow at a CAGR of 6.7% during the forecast period. However, the gradual slowing down of industries will undoubtedly impose limits on the previously estimated growth rate.

Pancreatic cancer is defined as a type of cancer that occurs within the tissues of the pancreas. The pancreas is located behind the stomach and it aids in digestion by producing enzymes needed by the body to digest fats, proteins, and carbohydrates.

It also produces hormones that control blood sugar levels in the body. It can be diagnosed using various tests including CT scan, magnetic resonance imaging, biopsy, and blood test among others.

The global market growth is primarily driven by the rising number of people having pancreatic cancer due to obesity, high consumption of alcohol, and smoking. Expand geriatric population is likely to drive the market growth further. It can also occur as a result of a family history of pancreatitis mutation. Increasing investment in research and development activities to develop advanced diagnostic solutions is likely to contribute to the market growth substantially. However, the high treatment cost is likely to affect the growth of the pancreatic cancer diagnostic market.

Based on the test, the market has been divided into imaging test, biopsy, blood test and other. The imaging segment accounted for the largest share in 2020 and is expected to continue its dominance during the review period as it helps to detect cancer at an early stage. The biopsy segment is projected to register healthy growth during the review period.

The market in North America accounted for the largest share in 2020 owing to rising incidences of pancreatic cancer, expanding geriatric population, and availability of advanced diagnosis solutions. The market in the Asia-Pacific region is projected to register a healthy growth rate on account of an increasing number of people having pancreatic cancer couples with the availability of advanced treatment facilities.

Key Players:

Key players operating in the global Pancreatic Cancer Diagnostic market are-

  • F. Hoffmann-La Roche AG (Switzerland),
  • Myriad Genetics (The U.S),
  • GE Healthcare (The U.S),
  • BD (India),
  • Koninklijke Philips N.V. (Netherlands),
  • Siemens AG (Germany),
  • Abbott Laboratories (The U.S),
  • Hitachi Medical Corporation (Japan),
  • Canon Medical Systems Corporation (Japan),
  • Danaher Corporation (The U.S),
  • Qiagen (Germany),
  • BioMarker Strategies (The U.S), and
  • Asuragen, Inc. (The U.S).

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Pancreatic Cancer Diagnostic analysis report discusses the following heads in great detail:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • COVID-19 Impact Assessment
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors 

Know more about Stratview Research:

Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.

Need a detailed report? Get in touch with us: 

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176